Institution
Tohoku University
Also known as: Tōhoku daigaku · 東北大学
- 5running trials
- 2closed trials
- 297,277publications (OpenAlex)
Running trials
Recruiting
Recruiting
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Active, not recruiting
Recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Ovarian cancer2 recruiting
- Childhood cancers1 recruiting
- Congenital heart disease1 recruiting
- High blood pressure1 recruiting
- Pulmonary arterial hypertension1 recruiting
Closed trials
Registry name variants (3)
Trial registries list this institution under these names. Each row is one registry entry: its address and the trials registered under it.
Tohoku University School of Medicine
Sendai, Aoba-ku 980-8574
5 trials
Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine
Sendai
1 trial
Tohoku University Graduate School of Medicine
Sendai, Miyagi 980-8574
1 trial
Conditions
Diseases this institution publishes on or runs trials for.
- Pancreatic cancer53 works · 0 trials
- Gastric and oesophageal cancer51 works · 0 trials
- Autism23 works · 0 trials
- Glaucoma17 works · 0 trials
- Systemic sclerosis (scleroderma)11 works · 0 trials
- Sarcoidosis9 works · 0 trials
- Irritable bowel syndrome7 works · 0 trials
- Hydrocephalus7 works · 0 trials
- Optic neuritis7 works · 0 trials
- Osteonecrosis (avascular necrosis)6 works · 0 trials
- Neuromyelitis optica (NMOSD)5 works · 0 trials
- Thymoma and thymic carcinoma4 works · 0 trials
- Haemophagocytic lymphohistiocytosis3 works · 0 trials
- Fabry disease3 works · 0 trials
Institution data: ROR 01dq60k83 (CC0-1.0)Updated 15 Nov 2026